StockGlow

Guided Therapeutics, Inc. (GTHP)

Makes a scanner that detects cervical cancer without invasive procedures.

$0.24-0.08%Healthcare
Compare GTHP with
StockGlow Score
34
Leaning Bearish
BearishBullish
1 year ago-2.4%

The outlook

GTHP is trading near the lower end of its 52-week range, roughly 29% up from its low, with a mixed position relative to its moving averages. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current market data.

What’s behind the score

Price trendMixed vs its moving averages
52-week range29% of the way from its 52-week low to high
Market cap
$23.6M
52-wk high
$0.54
52-wk low
$0.12
50-day avg
$0.24
200-day avg
$0.28
Trailing P/E
—

Similar stocks

BICXBioCorRx Inc.$0.30+20.00%RGRXRegeneRx Biopharmaceuticals, Inc.$0.00+0.00%NEPHNephros, Inc.$3.50+2.98%AMBSAmarantus BioScience Holdings, Inc.$0.00+0.00%LLBOLifeline Biotechnologies, Inc.$0.00+40.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy